Global Atovaquone and Proguanil Market Growth 2025-2031

October 2025 | 78 pages | ID: GEB9F6D851FEN
LP Information

Abstracts

The global Atovaquone and Proguanil market size is predicted to grow from US$ 146 million in 2025 to US$ 211 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum.

United States market for Atovaquone and Proguanil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Atovaquone and Proguanil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Atovaquone and Proguanil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Atovaquone and Proguanil players cover GSK, Glenmark, Mylan Pharmaceuticals, Hetero, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Atovaquone and Proguanil Industry Forecast? looks at past sales and reviews total world Atovaquone and Proguanil sales in 2024, providing a comprehensive analysis by region and market sector of projected Atovaquone and Proguanil sales for 2025 through 2031. With Atovaquone and Proguanil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atovaquone and Proguanil industry.

This Insight Report provides a comprehensive analysis of the global Atovaquone and Proguanil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atovaquone and Proguanil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Atovaquone and Proguanil market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atovaquone and Proguanil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atovaquone and Proguanil.

This report presents a comprehensive overview, market shares, and growth opportunities of Atovaquone and Proguanil market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 250 mg/100 mg
• 62.5mg/25mg

Segmentation by Application:

• Adult
• Paediatric

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• GSK
• Glenmark
• Mylan Pharmaceuticals
• Hetero

Key Questions Addressed in this Report

What is the 10-year outlook for the global Atovaquone and Proguanil market?
What factors are driving Atovaquone and Proguanil market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atovaquone and Proguanil market opportunities vary by end market size?
How does Atovaquone and Proguanil break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Atovaquone and Proguanil Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Atovaquone and Proguanil by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Atovaquone and Proguanil by Country/Region, 2020, 2024 & 2031
2.2 Atovaquone and Proguanil Segment by Type
  2.2.1 250 mg/100 mg
  2.2.2 62.5mg/25mg
2.3 Atovaquone and Proguanil Sales by Type
  2.3.1 Global Atovaquone and Proguanil Sales Market Share by Type (2020-2025)
  2.3.2 Global Atovaquone and Proguanil Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Atovaquone and Proguanil Sale Price by Type (2020-2025)
2.4 Atovaquone and Proguanil Segment by Application
  2.4.1 Adult
  2.4.2 Paediatric
2.5 Atovaquone and Proguanil Sales by Application
  2.5.1 Global Atovaquone and Proguanil Sale Market Share by Application (2020-2025)
  2.5.2 Global Atovaquone and Proguanil Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Atovaquone and Proguanil Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Atovaquone and Proguanil Breakdown Data by Company
  3.1.1 Global Atovaquone and Proguanil Annual Sales by Company (2020-2025)
  3.1.2 Global Atovaquone and Proguanil Sales Market Share by Company (2020-2025)
3.2 Global Atovaquone and Proguanil Annual Revenue by Company (2020-2025)
  3.2.1 Global Atovaquone and Proguanil Revenue by Company (2020-2025)
  3.2.2 Global Atovaquone and Proguanil Revenue Market Share by Company (2020-2025)
3.3 Global Atovaquone and Proguanil Sale Price by Company
3.4 Key Manufacturers Atovaquone and Proguanil Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Atovaquone and Proguanil Product Location Distribution
  3.4.2 Players Atovaquone and Proguanil Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ATOVAQUONE AND PROGUANIL BY GEOGRAPHIC REGION

4.1 World Historic Atovaquone and Proguanil Market Size by Geographic Region (2020-2025)
  4.1.1 Global Atovaquone and Proguanil Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Atovaquone and Proguanil Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Atovaquone and Proguanil Market Size by Country/Region (2020-2025)
  4.2.1 Global Atovaquone and Proguanil Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Atovaquone and Proguanil Annual Revenue by Country/Region (2020-2025)
4.3 Americas Atovaquone and Proguanil Sales Growth
4.4 APAC Atovaquone and Proguanil Sales Growth
4.5 Europe Atovaquone and Proguanil Sales Growth
4.6 Middle East & Africa Atovaquone and Proguanil Sales Growth

5 AMERICAS

5.1 Americas Atovaquone and Proguanil Sales by Country
  5.1.1 Americas Atovaquone and Proguanil Sales by Country (2020-2025)
  5.1.2 Americas Atovaquone and Proguanil Revenue by Country (2020-2025)
5.2 Americas Atovaquone and Proguanil Sales by Type (2020-2025)
5.3 Americas Atovaquone and Proguanil Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Atovaquone and Proguanil Sales by Region
  6.1.1 APAC Atovaquone and Proguanil Sales by Region (2020-2025)
  6.1.2 APAC Atovaquone and Proguanil Revenue by Region (2020-2025)
6.2 APAC Atovaquone and Proguanil Sales by Type (2020-2025)
6.3 APAC Atovaquone and Proguanil Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Atovaquone and Proguanil by Country
  7.1.1 Europe Atovaquone and Proguanil Sales by Country (2020-2025)
  7.1.2 Europe Atovaquone and Proguanil Revenue by Country (2020-2025)
7.2 Europe Atovaquone and Proguanil Sales by Type (2020-2025)
7.3 Europe Atovaquone and Proguanil Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Atovaquone and Proguanil by Country
  8.1.1 Middle East & Africa Atovaquone and Proguanil Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Atovaquone and Proguanil Revenue by Country (2020-2025)
8.2 Middle East & Africa Atovaquone and Proguanil Sales by Type (2020-2025)
8.3 Middle East & Africa Atovaquone and Proguanil Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atovaquone and Proguanil
10.3 Manufacturing Process Analysis of Atovaquone and Proguanil
10.4 Industry Chain Structure of Atovaquone and Proguanil

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Atovaquone and Proguanil Distributors
11.3 Atovaquone and Proguanil Customer

12 WORLD FORECAST REVIEW FOR ATOVAQUONE AND PROGUANIL BY GEOGRAPHIC REGION

12.1 Global Atovaquone and Proguanil Market Size Forecast by Region
  12.1.1 Global Atovaquone and Proguanil Forecast by Region (2026-2031)
  12.1.2 Global Atovaquone and Proguanil Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Atovaquone and Proguanil Forecast by Type (2026-2031)
12.7 Global Atovaquone and Proguanil Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 GSK
  13.1.1 GSK Company Information
  13.1.2 GSK Atovaquone and Proguanil Product Portfolios and Specifications
  13.1.3 GSK Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 GSK Main Business Overview
  13.1.5 GSK Latest Developments
13.2 Glenmark
  13.2.1 Glenmark Company Information
  13.2.2 Glenmark Atovaquone and Proguanil Product Portfolios and Specifications
  13.2.3 Glenmark Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Glenmark Main Business Overview
  13.2.5 Glenmark Latest Developments
13.3 Mylan Pharmaceuticals
  13.3.1 Mylan Pharmaceuticals Company Information
  13.3.2 Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolios and Specifications
  13.3.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Mylan Pharmaceuticals Main Business Overview
  13.3.5 Mylan Pharmaceuticals Latest Developments
13.4 Hetero
  13.4.1 Hetero Company Information
  13.4.2 Hetero Atovaquone and Proguanil Product Portfolios and Specifications
  13.4.3 Hetero Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Hetero Main Business Overview
  13.4.5 Hetero Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Atovaquone and Proguanil Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Atovaquone and Proguanil Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 250 mg/100 mg
Table 4. Major Players of 62.5mg/25mg
Table 5. Global Atovaquone and Proguanil Sales by Type (2020-2025) & (K Units)
Table 6. Global Atovaquone and Proguanil Sales Market Share by Type (2020-2025)
Table 7. Global Atovaquone and Proguanil Revenue by Type (2020-2025) & ($ million)
Table 8. Global Atovaquone and Proguanil Revenue Market Share by Type (2020-2025)
Table 9. Global Atovaquone and Proguanil Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Atovaquone and Proguanil Sale by Application (2020-2025) & (K Units)
Table 11. Global Atovaquone and Proguanil Sale Market Share by Application (2020-2025)
Table 12. Global Atovaquone and Proguanil Revenue by Application (2020-2025) & ($ million)
Table 13. Global Atovaquone and Proguanil Revenue Market Share by Application (2020-2025)
Table 14. Global Atovaquone and Proguanil Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Atovaquone and Proguanil Sales by Company (2020-2025) & (K Units)
Table 16. Global Atovaquone and Proguanil Sales Market Share by Company (2020-2025)
Table 17. Global Atovaquone and Proguanil Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Atovaquone and Proguanil Revenue Market Share by Company (2020-2025)
Table 19. Global Atovaquone and Proguanil Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Atovaquone and Proguanil Producing Area Distribution and Sales Area
Table 21. Players Atovaquone and Proguanil Products Offered
Table 22. Atovaquone and Proguanil Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Atovaquone and Proguanil Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Atovaquone and Proguanil Sales Market Share Geographic Region (2020-2025)
Table 27. Global Atovaquone and Proguanil Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Atovaquone and Proguanil Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Atovaquone and Proguanil Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Atovaquone and Proguanil Sales Market Share by Country/Region (2020-2025)
Table 31. Global Atovaquone and Proguanil Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Atovaquone and Proguanil Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Atovaquone and Proguanil Sales by Country (2020-2025) & (K Units)
Table 34. Americas Atovaquone and Proguanil Sales Market Share by Country (2020-2025)
Table 35. Americas Atovaquone and Proguanil Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Atovaquone and Proguanil Sales by Type (2020-2025) & (K Units)
Table 37. Americas Atovaquone and Proguanil Sales by Application (2020-2025) & (K Units)
Table 38. APAC Atovaquone and Proguanil Sales by Region (2020-2025) & (K Units)
Table 39. APAC Atovaquone and Proguanil Sales Market Share by Region (2020-2025)
Table 40. APAC Atovaquone and Proguanil Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Atovaquone and Proguanil Sales by Type (2020-2025) & (K Units)
Table 42. APAC Atovaquone and Proguanil Sales by Application (2020-2025) & (K Units)
Table 43. Europe Atovaquone and Proguanil Sales by Country (2020-2025) & (K Units)
Table 44. Europe Atovaquone and Proguanil Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Atovaquone and Proguanil Sales by Type (2020-2025) & (K Units)
Table 46. Europe Atovaquone and Proguanil Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Atovaquone and Proguanil Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Atovaquone and Proguanil Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Atovaquone and Proguanil Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Atovaquone and Proguanil Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Atovaquone and Proguanil
Table 52. Key Market Challenges & Risks of Atovaquone and Proguanil
Table 53. Key Industry Trends of Atovaquone and Proguanil
Table 54. Atovaquone and Proguanil Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Atovaquone and Proguanil Distributors List
Table 57. Atovaquone and Proguanil Customer List
Table 58. Global Atovaquone and Proguanil Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Atovaquone and Proguanil Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Atovaquone and Proguanil Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Atovaquone and Proguanil Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Atovaquone and Proguanil Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Atovaquone and Proguanil Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Atovaquone and Proguanil Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Atovaquone and Proguanil Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Atovaquone and Proguanil Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Atovaquone and Proguanil Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Atovaquone and Proguanil Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Atovaquone and Proguanil Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Atovaquone and Proguanil Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Atovaquone and Proguanil Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. GSK Basic Information, Atovaquone and Proguanil Manufacturing Base, Sales Area and Its Competitors
Table 73. GSK Atovaquone and Proguanil Product Portfolios and Specifications
Table 74. GSK Atovaquone and Proguanil Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. GSK Main Business
Table 76. GSK Latest Developments
Table 77. Glenmark Basic Information, Atovaquone and Proguanil Manufacturing Base, Sales Area and Its Competitors
Table 78. Glenmark Atovaquone and Proguanil Product Portfolios and Specifications
Table 79. Glenmark Atovaquone and Proguanil Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Glenmark Main Business
Table 81. Glenmark Latest Developments
Table 82. Mylan Pharmaceuticals Basic Information, Atovaquone and Proguanil Manufacturing Base, Sales Area and Its Competitors
Table 83. Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolios and Specifications
Table 84. Mylan Pharmaceuticals Atovaquone and Proguanil Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Mylan Pharmaceuticals Main Business
Table 86. Mylan Pharmaceuticals Latest Developments
Table 87. Hetero Basic Information, Atovaquone and Proguanil Manufacturing Base, Sales Area and Its Competitors
Table 88. Hetero Atovaquone and Proguanil Product Portfolios and Specifications
Table 89. Hetero Atovaquone and Proguanil Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Hetero Main Business
Table 91. Hetero Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Atovaquone and Proguanil
Figure 2. Atovaquone and Proguanil Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atovaquone and Proguanil Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Atovaquone and Proguanil Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Atovaquone and Proguanil Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Atovaquone and Proguanil Sales Market Share by Country/Region (2024)
Figure 10. Atovaquone and Proguanil Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 250 mg/100 mg
Figure 12. Product Picture of 62.5mg/25mg
Figure 13. Global Atovaquone and Proguanil Sales Market Share by Type in 2025
Figure 14. Global Atovaquone and Proguanil Revenue Market Share by Type (2020-2025)
Figure 15. Atovaquone and Proguanil Consumed in Adult
Figure 16. Global Atovaquone and Proguanil Market: Adult (2020-2025) & (K Units)
Figure 17. Atovaquone and Proguanil Consumed in Paediatric
Figure 18. Global Atovaquone and Proguanil Market: Paediatric (2020-2025) & (K Units)
Figure 19. Global Atovaquone and Proguanil Sale Market Share by Application (2024)
Figure 20. Global Atovaquone and Proguanil Revenue Market Share by Application in 2025
Figure 21. Atovaquone and Proguanil Sales by Company in 2025 (K Units)
Figure 22. Global Atovaquone and Proguanil Sales Market Share by Company in 2025
Figure 23. Atovaquone and Proguanil Revenue by Company in 2025 ($ millions)
Figure 24. Global Atovaquone and Proguanil Revenue Market Share by Company in 2025
Figure 25. Global Atovaquone and Proguanil Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Atovaquone and Proguanil Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Atovaquone and Proguanil Sales 2020-2025 (K Units)
Figure 28. Americas Atovaquone and Proguanil Revenue 2020-2025 ($ millions)
Figure 29. APAC Atovaquone and Proguanil Sales 2020-2025 (K Units)
Figure 30. APAC Atovaquone and Proguanil Revenue 2020-2025 ($ millions)
Figure 31. Europe Atovaquone and Proguanil Sales 2020-2025 (K Units)
Figure 32. Europe Atovaquone and Proguanil Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Atovaquone and Proguanil Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Atovaquone and Proguanil Revenue 2020-2025 ($ millions)
Figure 35. Americas Atovaquone and Proguanil Sales Market Share by Country in 2025
Figure 36. Americas Atovaquone and Proguanil Revenue Market Share by Country (2020-2025)
Figure 37. Americas Atovaquone and Proguanil Sales Market Share by Type (2020-2025)
Figure 38. Americas Atovaquone and Proguanil Sales Market Share by Application (2020-2025)
Figure 39. United States Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Atovaquone and Proguanil Sales Market Share by Region in 2025
Figure 44. APAC Atovaquone and Proguanil Revenue Market Share by Region (2020-2025)
Figure 45. APAC Atovaquone and Proguanil Sales Market Share by Type (2020-2025)
Figure 46. APAC Atovaquone and Proguanil Sales Market Share by Application (2020-2025)
Figure 47. China Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 51. India Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Atovaquone and Proguanil Sales Market Share by Country in 2025
Figure 55. Europe Atovaquone and Proguanil Revenue Market Share by Country (2020-2025)
Figure 56. Europe Atovaquone and Proguanil Sales Market Share by Type (2020-2025)
Figure 57. Europe Atovaquone and Proguanil Sales Market Share by Application (2020-2025)
Figure 58. Germany Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 59. France Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Atovaquone and Proguanil Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Atovaquone and Proguanil Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Atovaquone and Proguanil Sales Market Share by Application (2020-2025)
Figure 66. Egypt Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Atovaquone and Proguanil Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Atovaquone and Proguanil in 2025
Figure 72. Manufacturing Process Analysis of Atovaquone and Proguanil
Figure 73. Industry Chain Structure of Atovaquone and Proguanil
Figure 74. Channels of Distribution
Figure 75. Global Atovaquone and Proguanil Sales Market Forecast by Region (2026-2031)
Figure 76. Global Atovaquone and Proguanil Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Atovaquone and Proguanil Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Atovaquone and Proguanil Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Atovaquone and Proguanil Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Atovaquone and Proguanil Revenue Market Share Forecast by Application (2026-2031)